Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Ovarian Research
Published in: Journal of Ovarian Research 1/2015

Open Access 01-12-2015 | Research

Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats

Authors: Fakhroddin Mesbah, Mohsen Moslem, Zahra Vojdani, Hossein Mirkhani

Published in: Journal of Ovarian Research | Issue 1/2015

Login to get access

Abstract

Background

Metformin decreases polycystic ovary syndrome (PCOS) symptoms, induces ovulation, and may improve developmental competence of in vitro oocyte maturation. This study was designed to define the effects of metformin on the characteristics of in vitro oocyte maturation in estradiol valerate (EV) PCOS-induced rats.

Methods

Forty-five adult female Sprague–Dawley rats were randomly divided into control; sham and PCOS-induced (treated by a single dose of estradiol valerate, 4 mg/rat, IM) groups. The body weight was measured weekly for 12 weeks. At the end of week 12, the serum levels of testosterone, estrogen, progesterone, LH, and FSH and blood glucose of all the rats were measured. About 380 cumulus oocyte complexes (control, 125; sham, 122; PCOS-induced rats, 133) were incubated in Ham’s F10 in the absence and/or presence of metformin (M 5−10) for 12, 24, 36, and 48 h. The cumulus cells expansion and nuclear and cytoplasmic maturation of the oocytes was evaluated using 1 % aceto-orcein staining, and transmission electron microscopy (TEM).

Results

No significant differences were observed in the body weight of the rats. The serum level of testosterone was reduced, and progesterone and LH were significantly increased in the PCOS-induced rats (p < 0.05). However, no significant differences were observed in the serum levels of estrogen and FSH among the groups. Blood glucose level was higher in the PCOS-induced rats than control, (p < 0.01). The expansion of cumulus cells was observed in the metformin-treated oocytes. The oocytes retrieved from PCOS-induced rats show a stage of meiotic division (GVBD, MI, A-T, and MII) in 57.12 % of metformin-untreated and fairly significantly increased to 64.28 % in metformin-treated oocytes, (p < 0.05), but no differences were observed in the MII stage within groups. The redistribution of some cytoplasmic organelles throughout the ooplasm, particularly the peripheral cortical granules, was defined in the metformin-treated oocytes.

Conclusions

Single dose of EV can creates a reversible PCO adult rat model. Metformin enhances the COCs to initiate meiotic resumption at the first 6 h of IVM. In our study the metformin inability to show all aspects of in vitro oocyte maturation and may be resulted from deficiency of EV to induce PCOS.
Literature
1.
Szilagyi A, Szabo I. Endocrine characteristics of polycystic ovary syndrome (PCOS). Indian J Exp Biol. 2003;41:694–700.PubMed
2.
3.
Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:524–9.CrossRefPubMed
4.
Salmi DJ, Zisser HC, Jovanovic L. Screening for and treatment of polycystic ovary syndrome in teenagers. Exp Biol Med (Maywood). 2004;229:369–77.
5.
Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Inter J of Women’s Health. 2011;3:25–35.CrossRef
6.
Kocak I, Ustun C. Effects of metformin on insulin resistance, androgen concentration, ovulation and pregnancy rates in women with polycystic ovary syndrome following laparoscopic ovarian drilling. J Obstet Gynaecol Res. 2006;32:292–8.CrossRefPubMed
7.
Costello MF, Eden JA. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril. 2003;79:1–13.CrossRefPubMed
8.
Lee MS, Kang SK, Lee BC, Hwang WS. The beneficial effects of insulin and metformin on in vitro developmental potential of porcine oocytes and embryos. Biol Reprod. 2005;73:1264–8.CrossRefPubMed
9.
Zhao JZ, Lin JJ, Yang HY, Zhang W, Huang XF, Huang YP. Effects of oral contraceptives and metformin on the outcome of in vitro maturation in infertile women with polycystic ovary syndrome. J Womens Health (Larchmt). 2010;19:261–5.CrossRef
10.
Tosca L, Chabrolle C, Uzbekova S, Dupont J. Effects of metformin on bovine granulosa cells steroidogenesis: possible involvement of adenosine 5' monophosphate-activated protein kinase (AMPK). Biol Reprod. 2007;76:368–78.CrossRefPubMed
11.
Bilodeau-Goeseels S, Sasseville M, Guillemette C, Richard FJ. Effects of adenosine monophosphate-activated kinase activators on bovine oocyte nuclear maturation in vitro. Mol Reprod Dev. 2007;74:1021–34.CrossRefPubMed
12.
Sabatini ME, Guo L, Lynch MP, Doyle JO, Lee H, Rueda BR, et al. Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation. J Ovarian Res. 2011;4:8.PubMedCentralCrossRefPubMed
13.
Hewitt DA, England GC. The effect of oocyte size and bitch age upon oocyte nuclear maturation in vitro. Theriogenology. 1998;49:957–66.CrossRefPubMed
14.
Oliveira e Silva I, Vasconcelos RB, Caetano JV, Gulart LV, Camargo LS, Bao SN, et al. Induction of reversible meiosis arrest of bovine oocytes using a two-step procedure under defined and nondefined conditions. Theriogenology. 2011;75:1115–24.CrossRefPubMed
15.
Nandi S, Ravindranatha BM, Gupta PS, Sarma PV. Timing of sequential changes in cumulus cells and first polar body extrusion during in vitro maturation of buffalo oocytes. Theriogenology. 2002;57:1151–9.CrossRefPubMed
16.
17.
Walters KA, Allan CM, Handelsman DJ. Rodent models for human polycystic ovary syndrome. Biol Reprod. 2012;86:149.CrossRefPubMed
18.
19.
Singh KB. Persistent estrus rat models of polycystic ovary disease: an update. Fertil Steril. 2005;84 Suppl 2:1228–34.CrossRefPubMed
20.
Lambert HH. Continuous red light induces persistent estrus without retinal degeneration in the albino rat. Endocrinology. 1975;97:208–10.CrossRefPubMed
21.
Manneras L, Cajander S, Holmang A, Seleskovic Z, Lystig T, Lonn M, et al. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology. 2007;148:3781–91.CrossRefPubMed
22.
Shirwalkar H, Modi DN, Maitra A. Exposure of adult rats to estradiol valerate induces ovarian cyst with early senescence of follicles. Mol Cell Endocrinol. 2007;272:22–37.CrossRefPubMed
23.
Stener-Victorin E, Kobayashi R, Watanabe O, Lundeberg T, Kurosawa M. Effect of electro-acupuncture stimulation of different frequencies and intensities on ovarian blood flow in anaesthetized rats with steroid-induced polycystic ovaries. Reprod Biol Endocrinol. 2004;2:16.PubMedCentralCrossRefPubMed
24.
Kafali H, Iriadam M, Ozardali I, Demir N. Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch Med Res. 2004;35:103–8.CrossRefPubMed
25.
Tyndall V, Broyde M, Sharpe R, Welsh M, Drake AJ, McNeilly AS. Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats. Reproduction. 2012;143:21–33.PubMedCentralCrossRefPubMed
26.
Dikmen A, Ergenoglu AM, Yeniel AO, Dilsiz OY, GulinnazErcan HY. Evaluation of glycemic and oxidative/antioxidative status in the estradiol valerate-induced PCOS model of rats. Eur J Obstet Gynecol Reprod Biol. 2012;160:55–9.CrossRefPubMed
27.
Mesbah F, Moslem M, Vojdani Z, Mirkhani H. Estradiol Valerate-induced Polycystic Ovary Syndrome: An Animal Model Study. Armeghan e Danesh. Winter. 2011;60:325–34. Article in Persian.
28.
Noorafshan A, Ahmadi M, Mesbah SF, Karbalay-Doust S. Stereological study of the effects of letrozole and estradiol valerate treatment on the ovary of rats. CERM. 2013;40(3):115–21.PubMedCentralPubMed
29.
Stener-Victorin E, Ploj K, Larsson BM, Holmang A. Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity. Reprod Biol Endocrinol. 2005;3:44.PubMedCentralCrossRefPubMed
30.
Chapman JC, Min SH, Freeh SM, Michael SD. The estrogen-injected female mouse: new insight into the etiology of PCOS. Reprod Biol Endocrinol. 2009;7:47.PubMedCentralCrossRefPubMed
31.
32.
33.
Cruz G, Barra R, Gonzalez D, Sotomayor-Zarate R, Lara HE. Temporal window in which exposure to estradiol permanently modifies ovarian function causing polycystic ovary morphology in rats. Fertil Steril. 2012;98:1283–90.CrossRefPubMed
34.
35.
Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18:671–83.CrossRefPubMed
36.
Kushnir VA, Halevy N, Barad DH, Albertini DF, Gleicher N. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome. J of Ovarian Research. 2015;8:45. doi:10.​1186/​s13048-015-0175-x.CrossRef
37.
Motta AB. Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2010;119:105–11.CrossRefPubMed
38.
Wei Z, Cao Y, Cong L, Zhou P, Zhang Z, Li J. Effect of metformin pretreatment on pregnancy outcome of in vitro matured oocytes retrieved from women with polycystic ovary syndrome. Fertil Steril. 2008;90:1149–54.CrossRefPubMed
39.
Mansfield R, Galea R, Brincat M, Hole D, Mason H. Metformin has direct effects on human ovarian steroidogenesis. Fertil Steril. 2003;79:956–62.CrossRefPubMed
40.
Aparicio IM, Garcia-Herreros M, O'Shea LC, Hensey C, Lonergan P, Fair T. Expression, regulation, and function of progesterone receptors in bovine cumulus oocyte complexes during in vitro maturation. Biol Reprod. 2011;84:910–21.CrossRefPubMed
41.
Siqueira LC, Barreta MH, Gasperin B, Bohrer R, Santos JT, Buratini Jr J, et al. Angiotensin II, progesterone, and prostaglandins are sequential steps in the pathway to bovine oocyte nuclear maturation. Theriogenology. 2012;77:1779–87.CrossRefPubMed
42.
Kolodziejczyk B, Duleba AJ, Spaczynski RZ, Pawelczyk L. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril. 2000;73:1149–54.CrossRefPubMed
43.
Nagyova E. Regulation of cumulus expansion and hyaluronan synthesis in porcine oocyte-cumulus complexes during in vitro maturation. Endocr Regul. 2012;46:225–35.CrossRefPubMed
44.
Yokoo M, Kimura N, Abe H, Sato E. Influence of hyaluronan accumulation during cumulus expansion on in vitro porcine oocyte maturation. Zygote. 2008;16:309–14.CrossRefPubMed
45.
Tosca L, Uzbekova S, Chabrolle C, Dupont J. Possible role of 5'AMP-activated protein kinase in the metformin-mediated arrest of bovine oocytes at the germinal vesicle stage during in vitro maturation. Biol Reprod. 2007;77:452–65.CrossRefPubMed
46.
Santiquet N, Sasseville M, Laforest M, Guillemette C, Gilchrist RB, Richard FJ. Activation of 5 Adenosine Monophosphate-Activated Protein Kinase Blocks Cumulus Cell Expansion through Inhibition of Protein Synthesis during In Vitro Maturation in Swine. Biol Reprod. 2014;91(2):51. doi:10.​1095/​biolreprod.​113.​116764.CrossRefPubMed
47.
Hatler TB, Hayes SH, Laranja da Fonseca LF, Silvia WJ. Relationship between endogenous progesterone and follicular dynamics in lactating dairy cows with ovarian follicular cysts. Biol Reprod. 2003;69:218–23.CrossRefPubMed
48.
LaRosa C, Downs SM. Stress stimulates AMP-activated protein kinase and meiotic resumption in mouse oocytes. Biol Reprod. 2006;74:585–92.CrossRefPubMed
49.
Hyttel P, Fair T, Callesen H, Greve T. Oocyte growth, capacitation and final maturation in cattle. Theriogenology. 1997;47:23–32.CrossRef
50.
Centurione L, Giampietro F, Sancilio S, Piccirilli M, Artese L, Tiboni GM, et al. Morphometric and ultrastructural analysis of human granulosa cells after gonadotrophin-releasing hormone agonist or antagonist. Reprod Biomed Online. 2010;20:625–33.CrossRefPubMed
51.
Nottola SA, Heyn R, Camboni A, Correr S, Macchiarelli G. Ultrastructural characteristics of human granulosa cells in a coculture system for in vitro fertilization. Microsc Res Tech. 2006;69:508–16.CrossRefPubMed
52.
Suzuki S, Kitai H, Tojo R, Seki K, Oba M, Fujiwara T, et al. Ultrastructure and some biologic properties of human oocytes and granulosa cells cultured in vitro. Fertil Steril. 1981;35:142–8.PubMed
53.
54.
Hyttel P, Xu KP, Smith S, Greve T. Ultrastructure of in-vitro oocyte maturation in cattle. J Reprod Fertil. 1986;78:615–25.CrossRefPubMed
Metadata
Title
Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats
Authors
Fakhroddin Mesbah
Mohsen Moslem
Zahra Vojdani
Hossein Mirkhani
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Ovarian Research / Issue 1/2015
Electronic ISSN: 1757-2215
DOI
https://doi.org/10.1186/s13048-015-0203-x

Other articles of this Issue 1/2015

Journal of Ovarian Research 1/2015 Go to the issue

Research

Lipoic acid decreases Mcl-1, Bcl-xL and up regulates Bim on ovarian carcinoma cells leading to cell death

Review

MicroRNAs in ovarian function and disorders

Research

Gene expression profiling of ovarian carcinomas and prognostic analysis of outcome

Research

The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma

Research

Expression of Lysine-specific demethylase 1 in human epithelial ovarian cancer

Research

Expression and localisation of c-kit and KITL in the adult human ovary